Antiplatelet and thrombolytic activity of phenolic-insistent fractions from the new-fangled stem of Ficus benghalensis with concurrent GC-MS analysis

Abstract

Ficus benghalensis is the ingredient of a variety of Ayurvedic herbal formulations for the management of blood-related illnesses. In the current study, the new-fangled stem ethanol extract fractions in chloroform and methanol (CFFB & MFFB) were assessed for antiplatelet, thrombolytic and toxicity studies, as well as for phytoconstituent identification GC/MS was performed. The dried powdered stem bud was extracted with 80% ethanol and successively fractionated by chloroform and methanol (CFFB & MFFB). The anti-platelet, anti-thrombotic, and thrombolytic, activity of CFFB & MFFB were tested in ex vivo mode and toxicity of methanol fraction (MFFB) was tested in in vivo. The chief feasible marker components for antiplatelet activity recognized by GC-MS in the MFFB are Diethyl phthalate, (E)-4-(3-Hydroxyprop-1-en-1-yl)-2-methoxyphenol, 7,9-Di-tert-butyl-1-oxaspiro (4,5) deca-6,9-diene-2,8-dione and trans-Sinapyl alcohol might act as irreversible cyclooxygenase inhibitors like Aspirin. In the study, at 50 μg/mL, the antiplatelet activity of CFFB, MFFB, and aspirin was 50.41, 82.19, and 86.34%, and a substantial adjournment in clot development was observed whereas CFFB at different dosages did not exhibit significant outcome on the adjournment of clot formation, antiplatelet, and antioxidant activity. The toxicity examination of MFFB did not confirm any substantial signs of toxicity and mortality up to 1.5 g/kg, b.w and non-toxic up to 1.0 g/kg, b.w which is capable of the comportment of atherothrombotic ailments. The MFFB exhibited anti-platelet, anti-thrombotic, thrombolytic, and anti-oxidant activity, and capacity to prevent cardiovascular disorders without causing toxicity.

Keywords

Ex vivo activity / Ficus benghalensis / Antiplatelet activity / Phenolic-insistent fractions / New-fangled stem / GC-MS analysis

References

[1] Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014; 34 (11): 2363- 2371.

[2] Bhatt DL. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease. Ame j Cardiol. 2009; 103 (3): 11A- 19A.

[3] Showkathali R, Natarajan A. Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review. Curr Cardiol Rev. 2012; 8 (3): 239- 249.

[4] Mega JL, Simon T. Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments. Lancet. 2015; 386 (9990): 281- 291.

[5] Kothapalli PK, Sanganal JS, Shridhar NB. Phytopharmacology of Ficus bengalensis-A review. Asian J of Pharmocol & Res. 2014; 4: 201- 204.

[6] Kumar S, Arif M, Shafi S, et al. Potential phytoconstituents of Ficus religiosa L. and Ficus benghalensis L. with special reference to the treatment of blood disorders. Med Plants Int J Phytomed & Rel Ind. 2022;14(2):221–232.

[7] Khaliq HA. A review of pharmacognostic, physicochemical, phytochemical and pharmacological studies on Ficus bengalensis L. J Sci Innovative Res. 2017; 6 (4): 151- 163.

[8] Woo HH, Kuleck G, Hirsch AM, Hawes MC. Flavonoids: signal molecules in plant development. In: Flavonoids in Cell Function. Boston, MA: Springer; 2002:51–60.

[9] Kumar S, Arif M, Kamal M, Jawaid T, Khan , et al. Ex vivo antiplatelet and thrombolytic activity of bioactive fractions from the new-fangled stem buds of Ficus religiosa L. With simultaneous GC-MS examination. Molecules. 2023;28:3918.

[10] Arif M, Sachan NK, Zaman K, et al. Anti-inflammatory, analgesic and antioxidant potential of the stem bark of Spondias mangifera Willd. Arch Biol Sci. 2011; 63 (2): 413- 419.

[11] Arif M, Zaman K, Sheeba F. Pharmacognostical studies and evaluation of total phenolic contents of trunk bark of Spondias mangifera Willd. NPR. 2009; 8 (2): 146- 150.

[12] Ansari VA, Arif M, Hussain M, et al. New 40-substituted benzoyl-β-D glycoside from the fruit pulp of Terminalia belerica with antiplatelet and antioxidant potency. Integr Med Res. 2016; 5 (4): 317- 323.

[13] Ansari VA, Arif M, Siddiqui HH, et al. Antiplatelet activity and isolation of triterpenoidal glycoside from ethanolic extract of Nepeta hindostana. OPEM. 2016; 16 (4): 333- 337.

[14] Barbanti M, Guizzardi S, Calanni F, et al. Antithrombotic and thrombolytic activity of sulodexide in rats. Int J Clin Lab Res. 1992; 22 (1): 179- 184.

[15] Chaudhary S, Godatwar PK, Sharma R. In vitro thrombolytic activity of Dhamasa (Fagonia arabica Linn.), Kushta (Saussurea lappa Decne.), and Guduchi (Tinospora cordifolia Thunb.). Ayu. 2015;36(4):421.

[16] Arif M, Fareed S, Hussain MS. Estimation of antioxidant activity of microwave assisted extraction of total phenolics and flavonoids contents of the fruit Spondias mangifera Willd. Asian J of Trad Med. 2011; 6 (4): 145- 153.

[17] OECD. Test No. 452: Chronic Toxicity Studies, OECD Guidelines for the Testing of Chemicals, Section 4. Paris, France: OECD Publishing; 2018.

[18] Arif M, Fareed S, Hussain T, et al. Adaptogenic activity of lanostane triterpenoid isolated from Carissa carandas fruit against physically and chemically challenged experimental mice. Pharmacog. J. 2013;5:216–220.

[19] Arif M, Fareed S, Rahman MA. Stress relaxant and antioxidant activities of acid glycoside from Spondias mangifera fruit against physically and chemically challenged albino mice. J. Pharm. Bioal. Sci. 2016;8:58–63.

[20] Qadir A, Khan N, Arif M, et al. Identification of phytobioconstituents present in Simmondsia chinensis L. seeds extract by GC-MS analysis. J Indian Chem Soc. 2022; 99(2):100354.

[21] Singh P, Arif M, Qadir A, et al. Simultaneous analytical efficiency evaluation using an HPTLC method for the analysis of syringic acid and vanillic acid and their antioxidant capacity from methanol extract of Ricinus communis L. and Euphorbia hirta L. J AOAC Int. 2021;104(4):1188–1195.

[22] Irino O, Saitoh K, Ohkubo K. Anti-platelet actions of salicylates: in vivo, ex vivo and in vitro effects of choline salicylate. Nihon Yakurigaku zasshi. Folia Pharmacol Jpn. 1985;86(1):17–23.

[23] Fisher M, Weiner B, Ockene IS, et al. Selective thromboxane inhibition: a new approach to antiplatelet therapy. Stroke. 1984; 15 (5): 813- 816.

[24] Iqbal SS, Mujahid M, Kashif SM, et al. Protection of hepatotoxicity using Spondias pinnata by prevention of ethanol-induced oxidative stress, DNA-damage and altered biochemical markers in Wistar rats. Integ Med Res. 2016; 5 (4): 267- 275.

RIGHTS & PERMISSIONS

2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).